ABUS vs MNST · P/E 5.4, rev $6.2M vs P/E 46, rev $8.29B
Arbutus Biopharma Corp (ABUS) versus Monster Beverage Corp (MNST) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Monster Beverage Corp (MNST) is a beverages - non-alcoholic company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported MNST revenue for 2025-12-31 was $8.29B. Net income was $1.91B. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
Not investment advice. Open the ABUS and MNST stock pages for the full models.
Not investment advice.